Concepedia

Len Verbeke

LV

14

Publications

1.8K

Citations

14

H-Index

2001

Active since

Affiliations

KU Leuven(Current)

University of Bonn

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Antwerp University Hospital

Universitair Ziekenhuis Leuven

Len Verbeke is an author at KU Leuven specializing in medicine, liver physiology, and health sciences.

Top concepts

Publications per year

2001–2020

14

Publications

14

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

, , +9

Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats

Len Verbeke, Ricard Farré, Jonel Trebicka et al. · Hepatology · 2013 · 256 citations · Full text

FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis

Len Verbeke, Inge Mannaerts, Robert Schierwagen et al. · Scientific Reports · 2016 · 225 citations · Full text

The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats

Len Verbeke, Ricard Farré, Bert Verbinnen et al. · American Journal Of Pathology · 2015 · 207 citations · Full text

, , +9

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

V. Cocquyt, Simon Van Belle, Robert Reinhardt et al. · European Journal of Cancer · 2001 · 147 citations

, , +8

Rows per page

1–5 of 14